Unichem Labs gets USFDA observations for its Pithampur API facility
Mumbai: Pharma Major, Unichem Laboratories Ltd's API manufacturing facility at Pithampur, Madhya Pradesh was inspected by USFDA from July 23-27 2018.
Four observations were made which do not impact continuity of the Company's business and its manufacturing activity, the company said in a filing with BSE.
The Company proposes to respond to these observations within 15 business days.
The Pithampur facility manufactures API for use in the production of formulations that are exported to the USA.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd